According to TipRanks.com, Keane is a 5-star analyst with an average return of 14.8% and a 65.5% success rate. Keane covers the Technology sector, focusing on stocks such as Automatic Data Processing, Fidelity National Info, and AvidXchange Holdings.
WNS has an analyst consensus of Strong Buy, with a price target consensus of $100.60, implying a 16.3% upside from current levels. In a report issued on January 19, Barrington also maintained a Buy rating on the stock with a $104.00 price target.
Based on WNS’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $274 million and net profit of $32.14 million. In comparison, last year the company earned revenue of $223 million and had a net profit of $29.23 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
WNS (Holdings) Ltd. is a global business process management company. It offers comprehensive data, voice, analytical and business transformation services with a blended onshore, nearshore and offshore delivery model. The company operates through two segments: WNS Global BPM and WNS Auto Claims BPM. The WNS Global BPM is delivered out of its delivery centers in China Costa Rica, India, the Philippines, Poland, Romania, South Africa, Sri Lanka, the United Kingdom and the U.S., as well as its subcontractors delivery center in China. This segment includes all of the company’s business activities with the exception of WNS Auto Claims BPM. The WNS Auto Claims BPM segment is automobile claims management business which is primarily based in the United Kingdom and is part of its insurance business unit. WNS (Holdings) was founded by Alan Stephen Dunning, David Charles Tibble and Neeraj Bhargava on February 18, 2002 and is headquartered in Mumbai, India.
Read More on WNS:
- United Airlines Holdings (UAL) Receives a Buy from Deutsche Bank
- Deutsche Bank Sticks to Their Buy Rating for Stryker (SYK)
- Deutsche Bank Sticks to Its Hold Rating for Edwards Lifesciences (EW)
- Deutsche Bank Remains a Hold on Discover Financial Services (DFS)
- Boston Scientific (BSX) Gets a Hold Rating from Deutsche Bank